(Q42649074)

4 November 2017

title

Advanced glycation end-products, anti-hypertensive treatment and diastolic function in patients with hypertension and diastolic dysfunction (English)

1 reference

4 November 2017

1 reference

1 reference

3

Casper G Schalkwijk

1 reference

4 November 2017

10

Adriaan A Voors

1 reference

4 November 2017

Jasper W L Hartog

1

1 reference

4 November 2017

Ruud M van de Wal

2

1 reference

4 November 2017

Toshio Miyata

4

1 reference

4 November 2017

Wybren Jaarsma

5

1 reference

4 November 2017

H W Thijs Plokker

6

1 reference

4 November 2017

Leen M van Wijk

7

1 reference

4 November 2017

Andries J Smit

8

1 reference

4 November 2017

Dirk J van Veldhuisen

9

1 reference

4 November 2017

publication date

12 February 2010

1 reference

European Journal of Heart Failure

4 November 2017

published in

1 reference

4 November 2017

volume

12

1 reference

4 November 2017

issue

4

1 reference

4 November 2017

page(s)

397-403

1 reference

Advanced glycation end-products (AGEs) and heart failure: pathophysiology and clinical implications

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

New concepts in diastolic dysfunction and diastolic heart failure: Part II: causal mechanisms and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Advanced glycation endproduct crosslinking in the cardiovascular system: potential therapeutic target for cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Clinical and prognostic value of advanced glycation end-products in chronic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

What mechanisms underlie diastolic dysfunction in heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Skin-autofluorescence, a measure of tissue advanced glycation end-products (AGEs), is related to diastolic function in dialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Angiotensin II receptor blockers and angiotensin converting enzyme inhibitors: implication of radical scavenging and transition metal chelation in inhibition of advanced glycation end product formation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Effect of valsartan, an angiotensin II receptor blocker, on markers of oxidation and glycation in Japanese type 2 diabetic subjects: blood pressure-independent effect of valsartan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Irbesartan treatment reduces biomarkers of inflammatory activity in patients with type 2 diabetes and microalbuminuria: an IRMA 2 substudy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Drawbacks and prognostic value of formulas estimating renal function in patients with chronic heart failure and systolic dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Simple non-invasive assessment of advanced glycation endproduct accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Skin autofluorescence, a measure of cumulative metabolic stress and advanced glycation end products, predicts mortality in hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Measurement of Nepsilon-(carboxymethyl)lysine and Nepsilon-(carboxyethyl)lysine in human plasma protein by stable-isotope-dilution tandem mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Ultrapure dialysate decreases plasma pentosidine, a marker of "carbonyl stress".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Accumulation of advanced glycation end products, measured as skin autofluorescence, in renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

The effect of alagebrium chloride (ALT-711), a novel glucose cross-link breaker, in the treatment of elderly patients with diastolic heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Letter by Hartog et al. regarding article, "Advanced glycation end products accumulate in vascular smooth muscle and modify vascular but not ventricular properties in elderly hypertensive canines".

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

Diastolic Stiffness of the Failing Diabetic Heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FEURJHF%2FHFQ001

21 January 2018

Identifiers

DOI

10.1093/EURJHF/HFQ001

1 reference

4 November 2017

1 reference